4. Segment Information and Concentrations (Tables)

6 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Segment Information

Segment information is reported as follows (foreign sales are principally to customers in Europe and Asia):

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2012
Net Sales	$	1,164,900	$	664,900		$	47,100		$	-		$	1,876,900
Foreign Sales		747,900		279,800			-			-			1,027,700
Profit (Loss)		157,200		68,200			(30,900	)		-			194,500
Assets		2,485,700		1,695,400			963,100			915,800			6,060,000
Long-Lived Asset Expenditures		7,100		700			-			-			7,800
Depreciation and Amortization		11,500		9,200			24,000			-			44,700
	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2011
Net Sales	$	1,108,500	$	89,100		$	-		$	-		$	1,197,600
Foreign Sales		755,100		8,400			-			-			763,500
Profit (Loss)		100,200		(117,800	)		(32,300	)		(33,600	)		(83,500	)
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		4,500		2,800			876,000			-			883,300
Depreciation and Amortization		12,300		27,800			12,000			-			52,100

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2012
Net Sales	$	2,229,700	$	949,200		$	49,700		$	-		$	3,228,600
Foreign Sales		1,369,600		519,000			-			-			1,888,600
Profit (Loss)		274,800		(66,100	)		(105,900	)		-			102,800
Assets		2,485,700		1,695,400			963,100			915,800			6,060,000
Long-Lived Asset Expenditures		9,200		18,100			-			-			27,300
Depreciation and Amortization		22,600		18,500			47,900			-			89,000
	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2011
Net Sales	$	2,183,600	$	554,900		$	-		$	-		$	2,738,500
Foreign Sales		1,363,700		121,100			-			-			1,484,800
Profit (Loss)		260,600		(176,400	)		(32,300	)		(58,200	)		(-6,300)
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		14,000		49,500			876,000			-			939,500
Depreciation and Amortization		24,300		63,000			12,000			-			99,300